NDC 55289-049

Carisoprodol

Carisoprodol

Carisoprodol is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Pd-rx Pharmaceuticals, Inc.. The primary component is Carisoprodol.

Product ID55289-049_84f0e47a-4ae9-e9d4-e053-2a91aa0a81ab
NDC55289-049
Product TypeHuman Prescription Drug
Proprietary NameCarisoprodol
Generic NameCarisoprodol
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1987-11-01
Marketing CategoryANDA / ANDA
Application NumberANDA087499
Labeler NamePD-Rx Pharmaceuticals, Inc.
Substance NameCARISOPRODOL
Active Ingredient Strength350 mg/1
Pharm ClassesCentrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC]
DEA ScheduleCIV
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 55289-049-01

100 TABLET in 1 BOTTLE, PLASTIC (55289-049-01)
Marketing Start Date2015-10-27
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 55289-049-60 [55289004960]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-10-27

NDC 55289-049-24 [55289004924]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-10-27

NDC 55289-049-30 [55289004930]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-10-27

NDC 55289-049-01 [55289004901]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-10-27

NDC 55289-049-15 [55289004915]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-10-27

NDC 55289-049-10 [55289004910]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-10-27

NDC 55289-049-90 [55289004990]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-10-27

NDC 55289-049-14 [55289004914]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-10-27

NDC 55289-049-20 [55289004920]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-10-27

NDC 55289-049-40 [55289004940]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-10-27

NDC 55289-049-98 [55289004998]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-10-27

NDC 55289-049-21 [55289004921]

Carisoprodol TABLET
Marketing CategoryANDA
Application NumberANDA087499
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2015-10-27

Drug Details

Active Ingredients

IngredientStrength
CARISOPRODOL350 mg/1

OpenFDA Data

SPL SET ID:88820a09-8541-438f-b39c-452b2fa25ec6
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197446
    • UPC Code
  • 0355289049906

    • Pharmacological Class

    • Centrally-mediated Muscle Relaxation [PE]
    • Muscle Relaxant [EPC]
    • Centrally-mediated Muscle Relaxation [PE]
    • Muscle Relaxant [EPC]

    NDC Crossover Matching brand name "Carisoprodol" or generic name "Carisoprodol"

    NDCBrand NameGeneric Name
    0143-1176CarisoprodolCarisoprodol
    0143-9749CarisoprodolCarisoprodol
    0591-5513CarisoprodolCarisoprodol
    0603-2582CarisoprodolCarisoprodol
    10544-033CarisoprodolCarisoprodol
    10544-088CARISOPRODOLCARISOPRODOL
    10544-132CarisoprodolCarisoprodol
    12634-437CarisoprodolCarisoprodol
    16571-780carisoprodolcarisoprodol
    16571-781carisoprodolcarisoprodol
    16714-510CarisoprodolCarisoprodol
    29033-207CarisoprodolCarisoprodol
    29033-214CarisoprodolCarisoprodol
    33261-387CarisoprodolCarisoprodol
    33358-064CARISOPRODOLCARISOPRODOL
    35356-721CarisoprodolCarisoprodol
    42254-068CarisoprodolCarisoprodol
    42543-434CARISOPRODOLCARISOPRODOL
    42543-700CARISOPRODOLCARISOPRODOL
    43063-302CarisoprodolCarisoprodol
    43063-824CarisoprodolCarisoprodol
    43353-102CARISOPRODOLCARISOPRODOL
    68071-2188CarisoprodolCarisoprodol
    68071-4263CarisoprodolCarisoprodol
    68071-4112CarisoprodolCarisoprodol
    68071-4610CARISOPRODOLCARISOPRODOL
    68387-600CarisoprodolCarisoprodol
    68788-6866CarisoprodolCarisoprodol
    68788-2582CarisoprodolCarisoprodol
    68788-9976CARISOPRODOLCARISOPRODOL
    70518-0704CarisoprodolCarisoprodol
    70518-1092CarisoprodolCarisoprodol
    70518-1401CarisoprodolCarisoprodol
    71335-0131CarisoprodolCarisoprodol
    71205-241CARISOPRODOLCARISOPRODOL
    71335-0407CarisoprodolCarisoprodol
    71335-0516CARISOPRODOLCARISOPRODOL
    71335-0693CARISOPRODOLCARISOPRODOL
    71610-097CARISOPRODOLCARISOPRODOL
    75921-513CARISOPRODOLCARISOPRODOL
    76333-135CarisoprodolCarisoprodol
    50090-0281CarisoprodolCarisoprodol
    49999-064CarisoprodolCarisoprodol
    50090-0280CarisoprodolCarisoprodol
    50090-2530CarisoprodolCarisoprodol
    50090-3232CarisoprodolCarisoprodol
    50090-3048CARISOPRODOLCARISOPRODOL
    50090-3211CarisoprodolCarisoprodol
    50090-2771CarisoprodolCarisoprodol
    50228-109CARISOPRODOLCARISOPRODOL
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.